← Back to headlines
Sutro Biopharma Reports Mixed Financial Results for Q4
Sutro Biopharma announced GAAP EPS of -$22.49, missing estimates, but reported revenue of $102.48 million, which beat expectations.
23 Mar, 20:14 — 23 Mar, 20:14
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Bureau of Customs Shreds P266 Million in Smuggled Cigarettes in Zamboanga City
just now
Customs Intercepts P156.4 Million in Smuggled Cigarettes at Davao Port
just now
Subic Bay Tourism Firm Flags Security Breach Involving Convicted American
just now